GE HealthCare To Acquire SOFIE Biosciences For $945M — Here’s What GEHC Investors Need To Know
GE HealthCare is adding SOFIE’s PET radiopharmaceutical manufacturing footprint and U.S. rights to FAPI-74 as it expands its presence in precision diagnostics.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo